Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chuah

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|February 9, 2020
High-dimensional immune-profiling in cancer: implications for immunotherapySamuel Chuah, Valerie Chew
Bioscience Reports|August 10, 2021
Immune implication of an autophagy-related prognostic signature in uveal melanomaSamuel Chuah, Valerie Chew
Bioconjugate Chemistry|October 11, 2016
Butelase-Mediated Ligation as an Efficient Bioconjugation Method for the Synthesis of Peptide DendrimersYuan Cao, Giang K T Nguyen, Samuel Chuah, et al.
NPJ Precision Oncology|February 11, 2026
Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Wei Qiang Leow, et al.
Nature Medicine|February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialHyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Journal of Hepatology|April 17, 2022
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinomaSamuel Chuah, Joycelyn Lee, Yuan Song, et al.
Cancer Letters|October 24, 2022
IFNγ<sup>-</sup>IL-17<sup>+</sup> CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Phuong H D Nguyen, et al.
Hepatology Communications|August 21, 2024
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinomaN Jannah M Nasir, Samuel Chuah, Timothy Shuen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|February 9, 2020
High-dimensional immune-profiling in cancer: implications for immunotherapySamuel Chuah, Valerie Chew
Bioscience Reports|August 10, 2021
Immune implication of an autophagy-related prognostic signature in uveal melanomaSamuel Chuah, Valerie Chew
Bioconjugate Chemistry|October 11, 2016
Butelase-Mediated Ligation as an Efficient Bioconjugation Method for the Synthesis of Peptide DendrimersYuan Cao, Giang K T Nguyen, Samuel Chuah, et al.
NPJ Precision Oncology|February 11, 2026
Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Wei Qiang Leow, et al.
Nature Medicine|February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialHyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Journal of Hepatology|April 17, 2022
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinomaSamuel Chuah, Joycelyn Lee, Yuan Song, et al.
Cancer Letters|October 24, 2022
IFNγ<sup>-</sup>IL-17<sup>+</sup> CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinomaYun Hua Lee, Samuel Chuah, Phuong H D Nguyen, et al.
Hepatology Communications|August 21, 2024
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinomaN Jannah M Nasir, Samuel Chuah, Timothy Shuen, et al.
Pageof 1